1Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy [ J]. N Engl J Med,1994, 330:1841. 被引量：1
2D' Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis [ J ]. Gastroenterology, 2001, 120 : 1323. 被引量：1
3van Assche G, D' Haens G, Moman M, et al. Randomized, double-blind comparison of 4mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis [ J ]. Gastroenteroloy, 2003, 125 : 1025. 被引量：1
4Rowe FA, Walker JH, Karp LC, et al. Factors predictive of response to cyclosporine treatment for severe, steroid-resistant ulcerative colitis [J]. Am J Gastroenterol, 2000, 95:2000. 被引量：1
5McCormack G, O' Donoghue D, Baird A. In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in vivo therapeutic response in ulcerative colitis [J]. Aliment Pharmacol Ther, 2001,15:665. 被引量：1
6Kusugami K, Ina K, Tsuzuki T, et al. Cyclosporine therapy for patients with steroid-resistant ulcerative colitis: a potential therapeutic approach. In: Shimoyama T, Axon A, Lee A, Podolsky DK, O 'Morain C, editors. Helicobacter meets inflammatory bowel disease[ M]. Tokyo: Medical Tribune, 2002, 25. 被引量：1
7Ina K, Kusugami K, Shimada M, et al. Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis [ J ]. Inflamm Bowel Dis, 2002,8:1. 被引量：1
8Lichtiger S, Present DH, Preliminary report: cyclosporin in treatment of severe active ulcerative colitis [J]. Lancet, 1990,336 : 16. 被引量：1
9Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease [J]. Dig Dis Sci, 1994,39:374. 被引量：1
10Targan SR, Hanauer SB, van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease [J]. N Engl J Med, 1997,337:1029. 被引量：1
